- Home
- LUCD vs AEI Comparison
LUCD vs AEI Comparison
Compare LUCD & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- AEI
- Stock Information
- Founded
- LUCD 2018
- AEI 2014
- Country
- LUCD United States
- AEI United States
- Employees
- LUCD N/A
- AEI N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AEI Building operators
- Sector
- LUCD Health Care
- AEI Real Estate
- Exchange
- LUCD Nasdaq
- AEI Nasdaq
- Market Cap
- LUCD 108.0M
- AEI 124.7M
- IPO Year
- LUCD 2021
- AEI N/A
- Fundamental
- Price
- LUCD $1.04
- AEI $2.71
- Analyst Decision
- LUCD Strong Buy
- AEI
- Analyst Count
- LUCD 5
- AEI 0
- Target Price
- LUCD $3.70
- AEI N/A
- AVG Volume (30 Days)
- LUCD 1.5M
- AEI 687.6K
- Earning Date
- LUCD 11-12-2025
- AEI 11-13-2025
- Dividend Yield
- LUCD N/A
- AEI N/A
- EPS Growth
- LUCD N/A
- AEI N/A
- EPS
- LUCD N/A
- AEI N/A
- Revenue
- LUCD $4,360,000.00
- AEI $16,069,911.00
- Revenue This Year
- LUCD $13.90
- AEI N/A
- Revenue Next Year
- LUCD $163.88
- AEI N/A
- P/E Ratio
- LUCD N/A
- AEI N/A
- Revenue Growth
- LUCD 14.74
- AEI 74.28
- 52 Week Low
- LUCD $0.75
- AEI $0.70
- 52 Week High
- LUCD $1.80
- AEI $4.55
- Technical
- Relative Strength Index (RSI)
- LUCD 43.56
- AEI 52.88
- Support Level
- LUCD $1.00
- AEI $2.41
- Resistance Level
- LUCD $1.06
- AEI $2.90
- Average True Range (ATR)
- LUCD 0.04
- AEI 0.41
- MACD
- LUCD -0.00
- AEI -0.09
- Stochastic Oscillator
- LUCD 28.57
- AEI 27.27
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.